RPL39P36

Across TCGA pan-cancer cohorts, RPL39P36 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of RPL39P36’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RPL39P36 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL39P36 is over-expressed in tumor, although a few such as THCA and PAAD show the opposite, repressed pattern.

BLCA, LIHC, and KIRC are the cancer types where RPL39P36 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL39P36 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.954	<.001	11	view →
LIHC	Male	II,III,IV	+1.006	<.001	9	view →
KIRC	All	All	+0.403	<.001	8	view →
HNSC	Male	All	+0.657	<.001	7	view →
STAD	All	II,III,IV	+0.845	<.001	6	view →
BRCA	All	II,III,IV	+0.486	<.001	6	view →
LUSC	All	II,III,IV	+0.684	<.001	5	view →
KICH	All	All	+0.585	<.001	5	view →
CHOL	All	II,III,IV	+2.335	.001	4	view →
THCA	All	All	−0.359	.001	3	view →
READ	All	III,IV	+1.045	.030	2	view →
ESCA	All	All	+0.553	.016	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

RPL39P36–BLCA

Open the BLCA breakdown →